Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae

Infection and Immunity

Volumn 76, Issue 5, 2008, Pages 2037-2043

  Pang, Bing ^a   Winn, Dana ^a   Johnson, Ryan ^a   Hong, Wenzhou ^a   West Barnette, Shayla ^a   Kock, Nancy ^a   Swords, W Edward ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOOLIGOSACCHARIDE; PHOSPHORYLCHOLINE; TOLL LIKE RECEPTOR 4; LIPID LINKED OLIGOSACCHARIDES; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CELL SUBPOPULATION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; IMMUNOFLUORESCENCE TEST; INOCULATION; LUNG CLEARANCE; LUNG INFECTION; LUNG PARENCHYMA; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BACTERIAL COUNT; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; C57BL MOUSE; IMMUNOLOGY; LUNG; MICROBIOLOGY; MOUSE MUTANT; PATHOLOGY; TIME;

ANIMALS; COLONY COUNT, MICROBIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHORYLCHOLINE; PNEUMONIA, BACTERIAL; TIME FACTORS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 42949161641     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01716-07     Document Type: Article

References (66)

1. Abe, Y., T. F. Murphy, S. Sethi, H. S. Faden, J. Dmochowski, Y. Harabuchi, and Y. M. Thanavala. 2002. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165:967-971.
2. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.
3. Apicella, M. A., J. M. Grittiss, and H. Schneider. 1994. Isolation and characterization of lipopolysaccharides, lipooligosaccharides and lipid A. Methods Enzymol. 235:242-252.
4. Bakaletz, L. O., B. J. Kennedy, L. A. Novotny, G. Duquesne, J. Cohen, and Y. Lobet. 1999. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect. Immun. 67:2746-2762.
5. Bakaletz, L. O., B. M. Tallan, T. Hoepf, T. F. DeMaria, H. G. Birck, and D. J. Lim. 1988. Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium. Infect. Immun. 56:331-335.
6. Berenson, C. S., T. F. Murphy, C. T. Wrona, and S. Sethi. 2005. Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infect. Immun. 73:2728-2735.
7. Campagnari, A. A., M. R. Gupta, K. C. Dudas, T. F. Murphy, and M. A. Apicella. 1987. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect. Immun. 55:882-887.
8. Cutter, D., K. W. Mason, A. P. Howell, D. L. Fink, B. A. Green, and I. J. St. Geme. 2002. Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice. J. Infect. Dis. 186:1115-1121.
9. Eldika, N., and S. Sethi. 2006. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 12:118-124.
10. Fan, X., H. Goldfine, E. Lysenko, and J. N. Weiser. 2001. The transfer of choline from the host to the bacterial cell surface requires glpQ in Haemophilus influenzae. Mol. Microbiol. 41:1029-1036.
11. Foxwell, A. R., J. M. Kyd, and A. W. Cripps. 1998. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol. Mol. Biol. Rev. 62:294-308.
12. Galdiero, M., M. Galdiero, E. Finamore, F. Rossano, M. Gambuzza, M. R. Catania, G. Teti, A. Midiri, and G. Mancuso. 2004. Haemophilus influenzae porin induces Toll-like receptor 2-mediated cytokine production in human monocytes and mouse macrophages. Infect. Immun. 72:1204-1209.
13. Gould, J. M., and J. N. Weiser. 2002. The inhibitory effect of C-reactive protein on bacterial phosphorylcholine platelet-activating factor receptor-mediated adherence is blocked by surfactant. J. Infect. Dis. 186:361-371.
14. Groeneveld, K., P. P. Eijk, L. van Alphen, H. M. Jansen, and H. C. Zanen. 1990. Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum. Am. Rev. Respir. Dis. 141:1316-1321.
15. Hong, W., K. Mason, J. A. Jurcisek, L. A. Novotny, L. O. Bakaletz, and W. E. Swords. 2007. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect. Immun. 75:958-965.
16. Hong, W., B. Pang, S. West-Barnette, and W. E. Swords. 2007. Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J. Bacteriol. 189: 8300-8307.
17. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749-3752.
18. Jones, P. A., N. A. Samuels, N. J. Phillips, R. S. Munson, J. A. Bozue, J. A. Arseneau, W. A. Nichols, A. Zaleski, B. W. Gibson, and M. A. Apicella. 2002. Haemophilus influenzae type B strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J. Biol. Chem. 277:14598-14611.
19. Kennedy, B. J., L. A. Novotny, J. A. Jurcisek, Y. Lobet, and L. O. Bakaletz. 2000. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infect. Immun. 68:2756-2765.
20. King, P. T., P. E. Hutchinson, P. D. Johnson, P. W. Holmes, N. J. Freezer, and S. R. Holdsworth. 2003. Adaptive immunity to nontypeable Haemophilus influenzae. Am. J. Respir. Crit. Care Med. 167:587-592.
21. Kyd, J. M., A. W. Cripps, L. A. Novotny, and L. O. Bakaletz. 2003. Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx. Infect. Immun. 71:4691-4699.
22. Lazou Ahren, I., A. Bjartell, A. Egesten, and K. Riesbeck. 2001. Lipopolysaccharide-binding protein increases toll-like receptor 4-dependent activation by nontypeable Haemophilus influenzae. J. Infect. Dis. 184:926-930.
23. Lee, N.-G., M. G. Sunshine, J. J. Engstrom, B. W. Gibson, and M. A. Apicella. 1995. Mutation of the htrB locus of Haemophilus influenzae non-typable strain 2019 is associated with modifications of lipid A and phosphorylation of the lipo-oligosaccharide. J. Biol. Chem. 270:27151-27159.
24. Lesse, A. J., A. A. Campagnari, W. E. Bittner, and M. A. Apicella. 1990. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis. J. Immunol. Methods 126:109-117.
25. Lysenko, E., A. J. Ratner, A. L. Nelson, and J. N. Weiser. 2005. The role of innate immune responses in the outcome of interspecies competition for colonization of mucosal surfaces. PLoS Pathog. 1:e1.
26. Lysenko, E., J. C. Richards, A. D. Cox, A. Stewart, A. Martin, M. Kapoor, and J. N. Weiser. 2000. The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing. Mol. Microbiol. 35:234-245.
27. Lysenko, E. S., J. Gould, R. Bals, J. M. Wilson, and J. N. Weiser. 2000. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect. Immun. 68:1664-1671.
28. Mannino, D. M. 2002. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121:121S-126S.
29. McMahon, M., T. F. Murphy, J. Kyd, and Y. Thanavala. 2005. Role of an immunodominant T cell epitope of the P6 protein of nontypeable Haemophilus influenzae in murine protective immunity. Vaccine 23:3590-3596.
30. Mogensen, T. H., S. R. Paludan, M. Kilian, and L. Ostergaard. 2006. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukoc. Biol. 80:267-277.
31. Moller, L. V., W. Timens, W. van der Bij, K. Kooi, B. de Wever, J. Dankert, and L. van Alphen. 1998. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am. J. Respir. Crit. Care Med. 157:950-956.
32. Moran, A. P., M. M. Prendergast, and B. J. Appelmelk. 1996. Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol. Med. Microbiol. 16:105-115.
33. Murphy, T. F., and L. C. Bartos. 1988. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect. Immun. 56:2673-2679.
34. Musser, J. M., S. J. Barenkamp, D. M. Granoff, and R. K. Selander. 1986. Genetic relationships of serologically nontypable and serotype b strains of Haemophilus influenzae. Infect. Immun. 52:183-191.
35. Neary, J. M., and T. F. Murphy. 2006. Antibodies directed at a conserved motif in loop 6 of outer membrane protein P2 of nontypeable Haemophilus influenzae recognize multiple strains in immunoassays. FEMS Immunol. Med. Microbiol. 46:251-261.
36. Neary, J. M., K. Yi, R. J. Karalus, and T. F. Murphy. 2001. Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains. Infect. Immun. 69:773-778.
37. Nichols, W. A., C. R. H. Raetz, T. Clementz, A. L. Smith, J. A. Hanson, M. R. Ketterer, M. Sunshine, and M. A. Apicella. 1997. htrB of Haemophilus influenzae: determination of biochemical activity and effects on virulence and lipooligosaccharide toxicity. J. Endotoxin Res. 4:163-172.
38. Novotny, L. A., J. A. Jurcisek, F. Godfroid, J. T. Poolman, P. A. Denoel, and L. O. Bakaletz. 2006. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae. Vaccine 24:4804-4811.
39. Preston, A., R. E. Mandrell, B. W. Gibson, and M. A. Apicella. 1996. The lipooligosaccharides of pathogenic gram-negative bacteria. Crit. Rev. Microbiol. 22:139-180.
40. Schweda, E. K., J. C. Richards, D. W. Hood, and E. R. Moxon. 2007. Expression and structural diversity of the lipopolysaccharide of Haemophilus influenzae: implication in virulence. Int. J. Med. Microbiol. 297:297-306.
41. Sethi, S., N. Evans, B. J. Grant, and T. F. Murphy. 2002. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 347:465-471.
42. Sethi, S., J. Maloney, L. Grove, C. Wrona, and C. S. Berenson. 2006. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173:991-998.
43. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review. Clin. Microbiol. Rev. 14:336-363.
44. Sethi, S., R. Sethi, K. Eschberger, P. Lobbins, X. Cai, B. J. Grant, and T. F. Murphy. 2007. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 176:356-361.
45. Shuto, T., A. Imasato, H. Jono, A. Sakai, H. Xu, T. Watanabe, D. R. Rixter, H. Kai, A. Andalibi, F. Linthicum, Y. L. Guan, J. Han, A. C. Cato, D. J. Lim, S. Akira, and J. D. Li. 2002. Glucocorticoids synergistically enhance non-typeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277:17263-17270.
46. Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-kappa B by nontypeable Hemophilus [sic] influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98:8774-8779.
47. Swords, W. E., B. Buscher, K. Ver Steeg, W. Nichols, A. Preston, J. N. Weiser, B. Gibson, and M. A. Apicella. 2000. Nontypeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells by an interaction of lipooligosaccharide with the PAF receptor. Mol. Microbiol. 37:13-27.
48. Swords, W. E., D. L. Chance, L. A. Cohn, J. Shao, M. A. Apicella, and A. L. Smith. 2002. Acylation of the lipooligosaccharide of Haemophilus influenzae and colonization: an htrB mutation diminishes the colonization of human airway epithelial cells. Infect. Immun. 70:4661-4668.
49. Swords, W. E., P. A. Jones, and M. A. Apicella. 2003. The lipooligosaccharides of Haemophilus influenzae: an interesting assortment of characters. J. Endotoxin Res. 9:131-144.
50. Swords, W. E., M. R. Ketterer, J. Shao, C. A. Campbell, J. N. Weiser, and M. A. Apicella. 2001. Binding of the nontypeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signaling. Cell. Microbiol. 8:525-536.
51. Swords, W. E., M. L. Moore, L. Godzicki, G. Bukofzer, M. J. Mitten, and J. VonCannon. 2004. Sialylation of lipooligosaccharides promotes biofilm formation by nontypeable Haemophilus influenzae. Infect. Immun. 72:106-113.
52. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-5396.
53. Toews, G. B., J. A. Hart, and E. J. Hansen. 1985. Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b. Infect. Immun. 48:343-349.
54. Toews, G. B., S. Viroslav, D. A. Hart, and E. J. Hansen. 1984. Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains. Infect. Immun. 45:437-442.
55. Tong, H. H., L. E. Blue, M. A. James, Y. P. Chen, and T. F. DeMaria. 2000. Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect. Immun. 68:4593-4597.
56. Tsai, C.-M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
57. Wang, B., D. J. Lim, J. Han, Y. S. Kim, C. B. Basbaum, and J.-D. Li. 2002. Novel cytoplasmic proteins of nontypeable Haemophilus influenzae up-regulate human MUC5AC mucin transcription via a positive p38 mitogen-activated protein kinase pathway and a negative phosphoinositide 3-kinase-Akt pathway. J. Biol. Chem. 277:949-957.
58. Wang, X., C. Moser, J. P. Louboutin, E. S. Lysenko, D. J. Weiner, J. N. Weiser, and J. M. Wilson. 2002. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168:810-815.
59. Weiser, J. N. 2000. The generation of diversity by Haemophilus influenzae. Trends Microbiol. 8:433-435.
60. Weiser, J. N., and N. Pan. 1998. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol. Microbiol. 30:767-775.
61. Weiser, J. N., N. Pan, K. L. McGowan, D. Musher, A. Martin, and J. Richards. 1998. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:631-640.
62. Weiser, J. N., M. Shchepetov, and S. T. Chong. 1997. Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect. Immun. 65:943-950.
63. Weiss, D. S., B. Raupach, K. Takeda, S. Akira, and A. Zychlinsky. 2004. Toll-like receptors are temporally involved in host defense. J. Immunol. 172:4463-4469.
64. West-Barnette, S., A. Rockel, and W. E. Swords. 2006. Biofilm growth increases phosphorylcholine content and decreases potency of nontypeable Haemophilus influenzae endotoxins. Infect. Immun. 74:1828-1836.
65. Wieland, C. W., S. Florquin, N. A. Maris, K. Hoebe, B. Beutler, K. Takeda, S. Akira, and T. van der Poll. 2005. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable Haemophilus influenzae from the mouse lung. J. Immunol. 175:6042-6049.
66. Yi, K., S. Sethi, and T. F. Murphy. 1997. Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. J. Infect. Dis. 176:1247-1252.